Global Oncology CRO Services Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global Oncology CRO Services market size will reach USD 1196 million in 2031, growing at a CAGR of 5.2% over the analysis period.
Oncology CRO (Contract Research Organization) services refer to the specialized range of research and support services provided by external organizations to pharmaceutical companies, biotechnology firms, and other entities involved in oncology drug development and research. These CROs possess in-depth expertise in the complex field of oncology, encompassing knowledge of cancer biology, various types of malignancies, and the latest advancements in oncology research. Their services typically include all stages of clinical trial management, from the initial design and planning of oncology trials, which involves formulating study protocols, defining endpoints, and selecting appropriate patient populations. They handle patient recruitment and enrollment, ensuring that participants meet the strict eligibility criteria for the trials. Oncology CROs also conduct data management and analysis, collecting, organizing, and interpreting the vast amounts of data generated during the trials to assess the safety and efficacy of new cancer treatments. Additionally, they may offer regulatory affairs support, helping clients navigate the complex and ever-evolving landscape of oncology drug approvals by regulatory authorities. These services are crucial in accelerating the development of innovative oncology therapies, as they allow companies to leverage the specialized skills and resources of CROs, ultimately leading to the discovery and approval of new drugs that can improve the lives of cancer patients.
This report is a detailed and comprehensive analysis for global Oncology CRO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncology CRO Services market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oncology CRO Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oncology CRO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oncology CRO Services market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology CRO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology CRO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalyst, Celerion, Parexel, Crown Bioscience, Novotech, Charles River Laboratories, Medelis, ProPharma, TD2 Oncology, Precision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncology CRO Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology CRO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology CRO Services, with revenue, gross margin, and global market share of Oncology CRO Services from 2020 to 2025.
Chapter 3, the Oncology CRO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oncology CRO Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology CRO Services.
Chapter 13, to describe Oncology CRO Services research findings and conclusion.
Oncology CRO (Contract Research Organization) services refer to the specialized range of research and support services provided by external organizations to pharmaceutical companies, biotechnology firms, and other entities involved in oncology drug development and research. These CROs possess in-depth expertise in the complex field of oncology, encompassing knowledge of cancer biology, various types of malignancies, and the latest advancements in oncology research. Their services typically include all stages of clinical trial management, from the initial design and planning of oncology trials, which involves formulating study protocols, defining endpoints, and selecting appropriate patient populations. They handle patient recruitment and enrollment, ensuring that participants meet the strict eligibility criteria for the trials. Oncology CROs also conduct data management and analysis, collecting, organizing, and interpreting the vast amounts of data generated during the trials to assess the safety and efficacy of new cancer treatments. Additionally, they may offer regulatory affairs support, helping clients navigate the complex and ever-evolving landscape of oncology drug approvals by regulatory authorities. These services are crucial in accelerating the development of innovative oncology therapies, as they allow companies to leverage the specialized skills and resources of CROs, ultimately leading to the discovery and approval of new drugs that can improve the lives of cancer patients.
This report is a detailed and comprehensive analysis for global Oncology CRO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncology CRO Services market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oncology CRO Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oncology CRO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oncology CRO Services market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology CRO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology CRO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalyst, Celerion, Parexel, Crown Bioscience, Novotech, Charles River Laboratories, Medelis, ProPharma, TD2 Oncology, Precision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oncology CRO Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Preclinical Oncology CRO Services
- Clinical Trial Management
- Others
- Pharmaceutical Companies
- Academic and Research Institutions
- Others
- Catalyst
- Celerion
- Parexel
- Crown Bioscience
- Novotech
- Charles River Laboratories
- Medelis
- ProPharma
- TD2 Oncology
- Precision
- Emerald Clinical
- Worldwide Clinical Trials
- Champions Oncology
- Medpace
- Allucent
- Atlantic Research Group
- Explicyte
- InnoSer
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology CRO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology CRO Services, with revenue, gross margin, and global market share of Oncology CRO Services from 2020 to 2025.
Chapter 3, the Oncology CRO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oncology CRO Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology CRO Services.
Chapter 13, to describe Oncology CRO Services research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncology CRO Services by Type
1.3.1 Overview: Global Oncology CRO Services Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Oncology CRO Services Consumption Value Market Share by Type in 2024
1.3.3 Preclinical Oncology CRO Services
1.3.4 Clinical Trial Management
1.3.5 Others
1.4 Global Oncology CRO Services Market by Application
1.4.1 Overview: Global Oncology CRO Services Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceutical Companies
1.4.3 Academic and Research Institutions
1.4.4 Others
1.5 Global Oncology CRO Services Market Size & Forecast
1.6 Global Oncology CRO Services Market Size and Forecast by Region
1.6.1 Global Oncology CRO Services Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Oncology CRO Services Market Size by Region, (2020-2031)
1.6.3 North America Oncology CRO Services Market Size and Prospect (2020-2031)
1.6.4 Europe Oncology CRO Services Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Oncology CRO Services Market Size and Prospect (2020-2031)
1.6.6 South America Oncology CRO Services Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Oncology CRO Services Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Catalyst
2.1.1 Catalyst Details
2.1.2 Catalyst Major Business
2.1.3 Catalyst Oncology CRO Services Product and Solutions
2.1.4 Catalyst Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Catalyst Recent Developments and Future Plans
2.2 Celerion
2.2.1 Celerion Details
2.2.2 Celerion Major Business
2.2.3 Celerion Oncology CRO Services Product and Solutions
2.2.4 Celerion Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Celerion Recent Developments and Future Plans
2.3 Parexel
2.3.1 Parexel Details
2.3.2 Parexel Major Business
2.3.3 Parexel Oncology CRO Services Product and Solutions
2.3.4 Parexel Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Parexel Recent Developments and Future Plans
2.4 Crown Bioscience
2.4.1 Crown Bioscience Details
2.4.2 Crown Bioscience Major Business
2.4.3 Crown Bioscience Oncology CRO Services Product and Solutions
2.4.4 Crown Bioscience Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Crown Bioscience Recent Developments and Future Plans
2.5 Novotech
2.5.1 Novotech Details
2.5.2 Novotech Major Business
2.5.3 Novotech Oncology CRO Services Product and Solutions
2.5.4 Novotech Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Novotech Recent Developments and Future Plans
2.6 Charles River Laboratories
2.6.1 Charles River Laboratories Details
2.6.2 Charles River Laboratories Major Business
2.6.3 Charles River Laboratories Oncology CRO Services Product and Solutions
2.6.4 Charles River Laboratories Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Charles River Laboratories Recent Developments and Future Plans
2.7 Medelis
2.7.1 Medelis Details
2.7.2 Medelis Major Business
2.7.3 Medelis Oncology CRO Services Product and Solutions
2.7.4 Medelis Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Medelis Recent Developments and Future Plans
2.8 ProPharma
2.8.1 ProPharma Details
2.8.2 ProPharma Major Business
2.8.3 ProPharma Oncology CRO Services Product and Solutions
2.8.4 ProPharma Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 ProPharma Recent Developments and Future Plans
2.9 TD2 Oncology
2.9.1 TD2 Oncology Details
2.9.2 TD2 Oncology Major Business
2.9.3 TD2 Oncology Oncology CRO Services Product and Solutions
2.9.4 TD2 Oncology Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 TD2 Oncology Recent Developments and Future Plans
2.10 Precision
2.10.1 Precision Details
2.10.2 Precision Major Business
2.10.3 Precision Oncology CRO Services Product and Solutions
2.10.4 Precision Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Precision Recent Developments and Future Plans
2.11 Emerald Clinical
2.11.1 Emerald Clinical Details
2.11.2 Emerald Clinical Major Business
2.11.3 Emerald Clinical Oncology CRO Services Product and Solutions
2.11.4 Emerald Clinical Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Emerald Clinical Recent Developments and Future Plans
2.12 Worldwide Clinical Trials
2.12.1 Worldwide Clinical Trials Details
2.12.2 Worldwide Clinical Trials Major Business
2.12.3 Worldwide Clinical Trials Oncology CRO Services Product and Solutions
2.12.4 Worldwide Clinical Trials Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Worldwide Clinical Trials Recent Developments and Future Plans
2.13 Champions Oncology
2.13.1 Champions Oncology Details
2.13.2 Champions Oncology Major Business
2.13.3 Champions Oncology Oncology CRO Services Product and Solutions
2.13.4 Champions Oncology Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Champions Oncology Recent Developments and Future Plans
2.14 Medpace
2.14.1 Medpace Details
2.14.2 Medpace Major Business
2.14.3 Medpace Oncology CRO Services Product and Solutions
2.14.4 Medpace Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Medpace Recent Developments and Future Plans
2.15 Allucent
2.15.1 Allucent Details
2.15.2 Allucent Major Business
2.15.3 Allucent Oncology CRO Services Product and Solutions
2.15.4 Allucent Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Allucent Recent Developments and Future Plans
2.16 Atlantic Research Group
2.16.1 Atlantic Research Group Details
2.16.2 Atlantic Research Group Major Business
2.16.3 Atlantic Research Group Oncology CRO Services Product and Solutions
2.16.4 Atlantic Research Group Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Atlantic Research Group Recent Developments and Future Plans
2.17 Explicyte
2.17.1 Explicyte Details
2.17.2 Explicyte Major Business
2.17.3 Explicyte Oncology CRO Services Product and Solutions
2.17.4 Explicyte Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Explicyte Recent Developments and Future Plans
2.18 InnoSer
2.18.1 InnoSer Details
2.18.2 InnoSer Major Business
2.18.3 InnoSer Oncology CRO Services Product and Solutions
2.18.4 InnoSer Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 InnoSer Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncology CRO Services Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Oncology CRO Services by Company Revenue
3.2.2 Top 3 Oncology CRO Services Players Market Share in 2024
3.2.3 Top 6 Oncology CRO Services Players Market Share in 2024
3.3 Oncology CRO Services Market: Overall Company Footprint Analysis
3.3.1 Oncology CRO Services Market: Region Footprint
3.3.2 Oncology CRO Services Market: Company Product Type Footprint
3.3.3 Oncology CRO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncology CRO Services Consumption Value and Market Share by Type (2020-2025)
4.2 Global Oncology CRO Services Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncology CRO Services Consumption Value Market Share by Application (2020-2025)
5.2 Global Oncology CRO Services Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Oncology CRO Services Consumption Value by Type (2020-2031)
6.2 North America Oncology CRO Services Market Size by Application (2020-2031)
6.3 North America Oncology CRO Services Market Size by Country
6.3.1 North America Oncology CRO Services Consumption Value by Country (2020-2031)
6.3.2 United States Oncology CRO Services Market Size and Forecast (2020-2031)
6.3.3 Canada Oncology CRO Services Market Size and Forecast (2020-2031)
6.3.4 Mexico Oncology CRO Services Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Oncology CRO Services Consumption Value by Type (2020-2031)
7.2 Europe Oncology CRO Services Consumption Value by Application (2020-2031)
7.3 Europe Oncology CRO Services Market Size by Country
7.3.1 Europe Oncology CRO Services Consumption Value by Country (2020-2031)
7.3.2 Germany Oncology CRO Services Market Size and Forecast (2020-2031)
7.3.3 France Oncology CRO Services Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Oncology CRO Services Market Size and Forecast (2020-2031)
7.3.5 Russia Oncology CRO Services Market Size and Forecast (2020-2031)
7.3.6 Italy Oncology CRO Services Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncology CRO Services Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Oncology CRO Services Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Oncology CRO Services Market Size by Region
8.3.1 Asia-Pacific Oncology CRO Services Consumption Value by Region (2020-2031)
8.3.2 China Oncology CRO Services Market Size and Forecast (2020-2031)
8.3.3 Japan Oncology CRO Services Market Size and Forecast (2020-2031)
8.3.4 South Korea Oncology CRO Services Market Size and Forecast (2020-2031)
8.3.5 India Oncology CRO Services Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Oncology CRO Services Market Size and Forecast (2020-2031)
8.3.7 Australia Oncology CRO Services Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Oncology CRO Services Consumption Value by Type (2020-2031)
9.2 South America Oncology CRO Services Consumption Value by Application (2020-2031)
9.3 South America Oncology CRO Services Market Size by Country
9.3.1 South America Oncology CRO Services Consumption Value by Country (2020-2031)
9.3.2 Brazil Oncology CRO Services Market Size and Forecast (2020-2031)
9.3.3 Argentina Oncology CRO Services Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncology CRO Services Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Oncology CRO Services Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Oncology CRO Services Market Size by Country
10.3.1 Middle East & Africa Oncology CRO Services Consumption Value by Country (2020-2031)
10.3.2 Turkey Oncology CRO Services Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Oncology CRO Services Market Size and Forecast (2020-2031)
10.3.4 UAE Oncology CRO Services Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Oncology CRO Services Market Drivers
11.2 Oncology CRO Services Market Restraints
11.3 Oncology CRO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncology CRO Services Industry Chain
12.2 Oncology CRO Services Upstream Analysis
12.3 Oncology CRO Services Midstream Analysis
12.4 Oncology CRO Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncology CRO Services by Type
1.3.1 Overview: Global Oncology CRO Services Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Oncology CRO Services Consumption Value Market Share by Type in 2024
1.3.3 Preclinical Oncology CRO Services
1.3.4 Clinical Trial Management
1.3.5 Others
1.4 Global Oncology CRO Services Market by Application
1.4.1 Overview: Global Oncology CRO Services Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceutical Companies
1.4.3 Academic and Research Institutions
1.4.4 Others
1.5 Global Oncology CRO Services Market Size & Forecast
1.6 Global Oncology CRO Services Market Size and Forecast by Region
1.6.1 Global Oncology CRO Services Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Oncology CRO Services Market Size by Region, (2020-2031)
1.6.3 North America Oncology CRO Services Market Size and Prospect (2020-2031)
1.6.4 Europe Oncology CRO Services Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Oncology CRO Services Market Size and Prospect (2020-2031)
1.6.6 South America Oncology CRO Services Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Oncology CRO Services Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Catalyst
2.1.1 Catalyst Details
2.1.2 Catalyst Major Business
2.1.3 Catalyst Oncology CRO Services Product and Solutions
2.1.4 Catalyst Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Catalyst Recent Developments and Future Plans
2.2 Celerion
2.2.1 Celerion Details
2.2.2 Celerion Major Business
2.2.3 Celerion Oncology CRO Services Product and Solutions
2.2.4 Celerion Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Celerion Recent Developments and Future Plans
2.3 Parexel
2.3.1 Parexel Details
2.3.2 Parexel Major Business
2.3.3 Parexel Oncology CRO Services Product and Solutions
2.3.4 Parexel Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Parexel Recent Developments and Future Plans
2.4 Crown Bioscience
2.4.1 Crown Bioscience Details
2.4.2 Crown Bioscience Major Business
2.4.3 Crown Bioscience Oncology CRO Services Product and Solutions
2.4.4 Crown Bioscience Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Crown Bioscience Recent Developments and Future Plans
2.5 Novotech
2.5.1 Novotech Details
2.5.2 Novotech Major Business
2.5.3 Novotech Oncology CRO Services Product and Solutions
2.5.4 Novotech Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Novotech Recent Developments and Future Plans
2.6 Charles River Laboratories
2.6.1 Charles River Laboratories Details
2.6.2 Charles River Laboratories Major Business
2.6.3 Charles River Laboratories Oncology CRO Services Product and Solutions
2.6.4 Charles River Laboratories Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Charles River Laboratories Recent Developments and Future Plans
2.7 Medelis
2.7.1 Medelis Details
2.7.2 Medelis Major Business
2.7.3 Medelis Oncology CRO Services Product and Solutions
2.7.4 Medelis Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Medelis Recent Developments and Future Plans
2.8 ProPharma
2.8.1 ProPharma Details
2.8.2 ProPharma Major Business
2.8.3 ProPharma Oncology CRO Services Product and Solutions
2.8.4 ProPharma Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 ProPharma Recent Developments and Future Plans
2.9 TD2 Oncology
2.9.1 TD2 Oncology Details
2.9.2 TD2 Oncology Major Business
2.9.3 TD2 Oncology Oncology CRO Services Product and Solutions
2.9.4 TD2 Oncology Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 TD2 Oncology Recent Developments and Future Plans
2.10 Precision
2.10.1 Precision Details
2.10.2 Precision Major Business
2.10.3 Precision Oncology CRO Services Product and Solutions
2.10.4 Precision Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Precision Recent Developments and Future Plans
2.11 Emerald Clinical
2.11.1 Emerald Clinical Details
2.11.2 Emerald Clinical Major Business
2.11.3 Emerald Clinical Oncology CRO Services Product and Solutions
2.11.4 Emerald Clinical Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Emerald Clinical Recent Developments and Future Plans
2.12 Worldwide Clinical Trials
2.12.1 Worldwide Clinical Trials Details
2.12.2 Worldwide Clinical Trials Major Business
2.12.3 Worldwide Clinical Trials Oncology CRO Services Product and Solutions
2.12.4 Worldwide Clinical Trials Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Worldwide Clinical Trials Recent Developments and Future Plans
2.13 Champions Oncology
2.13.1 Champions Oncology Details
2.13.2 Champions Oncology Major Business
2.13.3 Champions Oncology Oncology CRO Services Product and Solutions
2.13.4 Champions Oncology Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Champions Oncology Recent Developments and Future Plans
2.14 Medpace
2.14.1 Medpace Details
2.14.2 Medpace Major Business
2.14.3 Medpace Oncology CRO Services Product and Solutions
2.14.4 Medpace Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Medpace Recent Developments and Future Plans
2.15 Allucent
2.15.1 Allucent Details
2.15.2 Allucent Major Business
2.15.3 Allucent Oncology CRO Services Product and Solutions
2.15.4 Allucent Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Allucent Recent Developments and Future Plans
2.16 Atlantic Research Group
2.16.1 Atlantic Research Group Details
2.16.2 Atlantic Research Group Major Business
2.16.3 Atlantic Research Group Oncology CRO Services Product and Solutions
2.16.4 Atlantic Research Group Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Atlantic Research Group Recent Developments and Future Plans
2.17 Explicyte
2.17.1 Explicyte Details
2.17.2 Explicyte Major Business
2.17.3 Explicyte Oncology CRO Services Product and Solutions
2.17.4 Explicyte Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Explicyte Recent Developments and Future Plans
2.18 InnoSer
2.18.1 InnoSer Details
2.18.2 InnoSer Major Business
2.18.3 InnoSer Oncology CRO Services Product and Solutions
2.18.4 InnoSer Oncology CRO Services Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 InnoSer Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oncology CRO Services Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Oncology CRO Services by Company Revenue
3.2.2 Top 3 Oncology CRO Services Players Market Share in 2024
3.2.3 Top 6 Oncology CRO Services Players Market Share in 2024
3.3 Oncology CRO Services Market: Overall Company Footprint Analysis
3.3.1 Oncology CRO Services Market: Region Footprint
3.3.2 Oncology CRO Services Market: Company Product Type Footprint
3.3.3 Oncology CRO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oncology CRO Services Consumption Value and Market Share by Type (2020-2025)
4.2 Global Oncology CRO Services Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oncology CRO Services Consumption Value Market Share by Application (2020-2025)
5.2 Global Oncology CRO Services Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Oncology CRO Services Consumption Value by Type (2020-2031)
6.2 North America Oncology CRO Services Market Size by Application (2020-2031)
6.3 North America Oncology CRO Services Market Size by Country
6.3.1 North America Oncology CRO Services Consumption Value by Country (2020-2031)
6.3.2 United States Oncology CRO Services Market Size and Forecast (2020-2031)
6.3.3 Canada Oncology CRO Services Market Size and Forecast (2020-2031)
6.3.4 Mexico Oncology CRO Services Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Oncology CRO Services Consumption Value by Type (2020-2031)
7.2 Europe Oncology CRO Services Consumption Value by Application (2020-2031)
7.3 Europe Oncology CRO Services Market Size by Country
7.3.1 Europe Oncology CRO Services Consumption Value by Country (2020-2031)
7.3.2 Germany Oncology CRO Services Market Size and Forecast (2020-2031)
7.3.3 France Oncology CRO Services Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Oncology CRO Services Market Size and Forecast (2020-2031)
7.3.5 Russia Oncology CRO Services Market Size and Forecast (2020-2031)
7.3.6 Italy Oncology CRO Services Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oncology CRO Services Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Oncology CRO Services Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Oncology CRO Services Market Size by Region
8.3.1 Asia-Pacific Oncology CRO Services Consumption Value by Region (2020-2031)
8.3.2 China Oncology CRO Services Market Size and Forecast (2020-2031)
8.3.3 Japan Oncology CRO Services Market Size and Forecast (2020-2031)
8.3.4 South Korea Oncology CRO Services Market Size and Forecast (2020-2031)
8.3.5 India Oncology CRO Services Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Oncology CRO Services Market Size and Forecast (2020-2031)
8.3.7 Australia Oncology CRO Services Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Oncology CRO Services Consumption Value by Type (2020-2031)
9.2 South America Oncology CRO Services Consumption Value by Application (2020-2031)
9.3 South America Oncology CRO Services Market Size by Country
9.3.1 South America Oncology CRO Services Consumption Value by Country (2020-2031)
9.3.2 Brazil Oncology CRO Services Market Size and Forecast (2020-2031)
9.3.3 Argentina Oncology CRO Services Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oncology CRO Services Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Oncology CRO Services Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Oncology CRO Services Market Size by Country
10.3.1 Middle East & Africa Oncology CRO Services Consumption Value by Country (2020-2031)
10.3.2 Turkey Oncology CRO Services Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Oncology CRO Services Market Size and Forecast (2020-2031)
10.3.4 UAE Oncology CRO Services Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Oncology CRO Services Market Drivers
11.2 Oncology CRO Services Market Restraints
11.3 Oncology CRO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oncology CRO Services Industry Chain
12.2 Oncology CRO Services Upstream Analysis
12.3 Oncology CRO Services Midstream Analysis
12.4 Oncology CRO Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Oncology CRO Services Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Oncology CRO Services Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Oncology CRO Services Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Oncology CRO Services Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Catalyst Company Information, Head Office, and Major Competitors
Table 6. Catalyst Major Business
Table 7. Catalyst Oncology CRO Services Product and Solutions
Table 8. Catalyst Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Catalyst Recent Developments and Future Plans
Table 10. Celerion Company Information, Head Office, and Major Competitors
Table 11. Celerion Major Business
Table 12. Celerion Oncology CRO Services Product and Solutions
Table 13. Celerion Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Celerion Recent Developments and Future Plans
Table 15. Parexel Company Information, Head Office, and Major Competitors
Table 16. Parexel Major Business
Table 17. Parexel Oncology CRO Services Product and Solutions
Table 18. Parexel Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Crown Bioscience Company Information, Head Office, and Major Competitors
Table 20. Crown Bioscience Major Business
Table 21. Crown Bioscience Oncology CRO Services Product and Solutions
Table 22. Crown Bioscience Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Crown Bioscience Recent Developments and Future Plans
Table 24. Novotech Company Information, Head Office, and Major Competitors
Table 25. Novotech Major Business
Table 26. Novotech Oncology CRO Services Product and Solutions
Table 27. Novotech Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Novotech Recent Developments and Future Plans
Table 29. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 30. Charles River Laboratories Major Business
Table 31. Charles River Laboratories Oncology CRO Services Product and Solutions
Table 32. Charles River Laboratories Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Charles River Laboratories Recent Developments and Future Plans
Table 34. Medelis Company Information, Head Office, and Major Competitors
Table 35. Medelis Major Business
Table 36. Medelis Oncology CRO Services Product and Solutions
Table 37. Medelis Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Medelis Recent Developments and Future Plans
Table 39. ProPharma Company Information, Head Office, and Major Competitors
Table 40. ProPharma Major Business
Table 41. ProPharma Oncology CRO Services Product and Solutions
Table 42. ProPharma Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. ProPharma Recent Developments and Future Plans
Table 44. TD2 Oncology Company Information, Head Office, and Major Competitors
Table 45. TD2 Oncology Major Business
Table 46. TD2 Oncology Oncology CRO Services Product and Solutions
Table 47. TD2 Oncology Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. TD2 Oncology Recent Developments and Future Plans
Table 49. Precision Company Information, Head Office, and Major Competitors
Table 50. Precision Major Business
Table 51. Precision Oncology CRO Services Product and Solutions
Table 52. Precision Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Precision Recent Developments and Future Plans
Table 54. Emerald Clinical Company Information, Head Office, and Major Competitors
Table 55. Emerald Clinical Major Business
Table 56. Emerald Clinical Oncology CRO Services Product and Solutions
Table 57. Emerald Clinical Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Emerald Clinical Recent Developments and Future Plans
Table 59. Worldwide Clinical Trials Company Information, Head Office, and Major Competitors
Table 60. Worldwide Clinical Trials Major Business
Table 61. Worldwide Clinical Trials Oncology CRO Services Product and Solutions
Table 62. Worldwide Clinical Trials Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Worldwide Clinical Trials Recent Developments and Future Plans
Table 64. Champions Oncology Company Information, Head Office, and Major Competitors
Table 65. Champions Oncology Major Business
Table 66. Champions Oncology Oncology CRO Services Product and Solutions
Table 67. Champions Oncology Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Champions Oncology Recent Developments and Future Plans
Table 69. Medpace Company Information, Head Office, and Major Competitors
Table 70. Medpace Major Business
Table 71. Medpace Oncology CRO Services Product and Solutions
Table 72. Medpace Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Medpace Recent Developments and Future Plans
Table 74. Allucent Company Information, Head Office, and Major Competitors
Table 75. Allucent Major Business
Table 76. Allucent Oncology CRO Services Product and Solutions
Table 77. Allucent Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Allucent Recent Developments and Future Plans
Table 79. Atlantic Research Group Company Information, Head Office, and Major Competitors
Table 80. Atlantic Research Group Major Business
Table 81. Atlantic Research Group Oncology CRO Services Product and Solutions
Table 82. Atlantic Research Group Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Atlantic Research Group Recent Developments and Future Plans
Table 84. Explicyte Company Information, Head Office, and Major Competitors
Table 85. Explicyte Major Business
Table 86. Explicyte Oncology CRO Services Product and Solutions
Table 87. Explicyte Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Explicyte Recent Developments and Future Plans
Table 89. InnoSer Company Information, Head Office, and Major Competitors
Table 90. InnoSer Major Business
Table 91. InnoSer Oncology CRO Services Product and Solutions
Table 92. InnoSer Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. InnoSer Recent Developments and Future Plans
Table 94. Global Oncology CRO Services Revenue (USD Million) by Players (2020-2025)
Table 95. Global Oncology CRO Services Revenue Share by Players (2020-2025)
Table 96. Breakdown of Oncology CRO Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 97. Market Position of Players in Oncology CRO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 98. Head Office of Key Oncology CRO Services Players
Table 99. Oncology CRO Services Market: Company Product Type Footprint
Table 100. Oncology CRO Services Market: Company Product Application Footprint
Table 101. Oncology CRO Services New Market Entrants and Barriers to Market Entry
Table 102. Oncology CRO Services Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Oncology CRO Services Consumption Value (USD Million) by Type (2020-2025)
Table 104. Global Oncology CRO Services Consumption Value Share by Type (2020-2025)
Table 105. Global Oncology CRO Services Consumption Value Forecast by Type (2026-2031)
Table 106. Global Oncology CRO Services Consumption Value by Application (2020-2025)
Table 107. Global Oncology CRO Services Consumption Value Forecast by Application (2026-2031)
Table 108. North America Oncology CRO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 109. North America Oncology CRO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 110. North America Oncology CRO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 111. North America Oncology CRO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 112. North America Oncology CRO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Oncology CRO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Oncology CRO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 115. Europe Oncology CRO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 116. Europe Oncology CRO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 117. Europe Oncology CRO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 118. Europe Oncology CRO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 119. Europe Oncology CRO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 120. Asia-Pacific Oncology CRO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 121. Asia-Pacific Oncology CRO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 122. Asia-Pacific Oncology CRO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 123. Asia-Pacific Oncology CRO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 124. Asia-Pacific Oncology CRO Services Consumption Value by Region (2020-2025) & (USD Million)
Table 125. Asia-Pacific Oncology CRO Services Consumption Value by Region (2026-2031) & (USD Million)
Table 126. South America Oncology CRO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 127. South America Oncology CRO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 128. South America Oncology CRO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 129. South America Oncology CRO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 130. South America Oncology CRO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 131. South America Oncology CRO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 132. Middle East & Africa Oncology CRO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 133. Middle East & Africa Oncology CRO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 134. Middle East & Africa Oncology CRO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 135. Middle East & Africa Oncology CRO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 136. Middle East & Africa Oncology CRO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 137. Middle East & Africa Oncology CRO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Global Key Players of Oncology CRO Services Upstream (Raw Materials)
Table 139. Global Oncology CRO Services Typical Customers
Table 1. Global Oncology CRO Services Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Oncology CRO Services Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Oncology CRO Services Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Oncology CRO Services Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Catalyst Company Information, Head Office, and Major Competitors
Table 6. Catalyst Major Business
Table 7. Catalyst Oncology CRO Services Product and Solutions
Table 8. Catalyst Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Catalyst Recent Developments and Future Plans
Table 10. Celerion Company Information, Head Office, and Major Competitors
Table 11. Celerion Major Business
Table 12. Celerion Oncology CRO Services Product and Solutions
Table 13. Celerion Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Celerion Recent Developments and Future Plans
Table 15. Parexel Company Information, Head Office, and Major Competitors
Table 16. Parexel Major Business
Table 17. Parexel Oncology CRO Services Product and Solutions
Table 18. Parexel Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Crown Bioscience Company Information, Head Office, and Major Competitors
Table 20. Crown Bioscience Major Business
Table 21. Crown Bioscience Oncology CRO Services Product and Solutions
Table 22. Crown Bioscience Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Crown Bioscience Recent Developments and Future Plans
Table 24. Novotech Company Information, Head Office, and Major Competitors
Table 25. Novotech Major Business
Table 26. Novotech Oncology CRO Services Product and Solutions
Table 27. Novotech Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Novotech Recent Developments and Future Plans
Table 29. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 30. Charles River Laboratories Major Business
Table 31. Charles River Laboratories Oncology CRO Services Product and Solutions
Table 32. Charles River Laboratories Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Charles River Laboratories Recent Developments and Future Plans
Table 34. Medelis Company Information, Head Office, and Major Competitors
Table 35. Medelis Major Business
Table 36. Medelis Oncology CRO Services Product and Solutions
Table 37. Medelis Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Medelis Recent Developments and Future Plans
Table 39. ProPharma Company Information, Head Office, and Major Competitors
Table 40. ProPharma Major Business
Table 41. ProPharma Oncology CRO Services Product and Solutions
Table 42. ProPharma Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. ProPharma Recent Developments and Future Plans
Table 44. TD2 Oncology Company Information, Head Office, and Major Competitors
Table 45. TD2 Oncology Major Business
Table 46. TD2 Oncology Oncology CRO Services Product and Solutions
Table 47. TD2 Oncology Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. TD2 Oncology Recent Developments and Future Plans
Table 49. Precision Company Information, Head Office, and Major Competitors
Table 50. Precision Major Business
Table 51. Precision Oncology CRO Services Product and Solutions
Table 52. Precision Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Precision Recent Developments and Future Plans
Table 54. Emerald Clinical Company Information, Head Office, and Major Competitors
Table 55. Emerald Clinical Major Business
Table 56. Emerald Clinical Oncology CRO Services Product and Solutions
Table 57. Emerald Clinical Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Emerald Clinical Recent Developments and Future Plans
Table 59. Worldwide Clinical Trials Company Information, Head Office, and Major Competitors
Table 60. Worldwide Clinical Trials Major Business
Table 61. Worldwide Clinical Trials Oncology CRO Services Product and Solutions
Table 62. Worldwide Clinical Trials Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Worldwide Clinical Trials Recent Developments and Future Plans
Table 64. Champions Oncology Company Information, Head Office, and Major Competitors
Table 65. Champions Oncology Major Business
Table 66. Champions Oncology Oncology CRO Services Product and Solutions
Table 67. Champions Oncology Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Champions Oncology Recent Developments and Future Plans
Table 69. Medpace Company Information, Head Office, and Major Competitors
Table 70. Medpace Major Business
Table 71. Medpace Oncology CRO Services Product and Solutions
Table 72. Medpace Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Medpace Recent Developments and Future Plans
Table 74. Allucent Company Information, Head Office, and Major Competitors
Table 75. Allucent Major Business
Table 76. Allucent Oncology CRO Services Product and Solutions
Table 77. Allucent Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Allucent Recent Developments and Future Plans
Table 79. Atlantic Research Group Company Information, Head Office, and Major Competitors
Table 80. Atlantic Research Group Major Business
Table 81. Atlantic Research Group Oncology CRO Services Product and Solutions
Table 82. Atlantic Research Group Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Atlantic Research Group Recent Developments and Future Plans
Table 84. Explicyte Company Information, Head Office, and Major Competitors
Table 85. Explicyte Major Business
Table 86. Explicyte Oncology CRO Services Product and Solutions
Table 87. Explicyte Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Explicyte Recent Developments and Future Plans
Table 89. InnoSer Company Information, Head Office, and Major Competitors
Table 90. InnoSer Major Business
Table 91. InnoSer Oncology CRO Services Product and Solutions
Table 92. InnoSer Oncology CRO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. InnoSer Recent Developments and Future Plans
Table 94. Global Oncology CRO Services Revenue (USD Million) by Players (2020-2025)
Table 95. Global Oncology CRO Services Revenue Share by Players (2020-2025)
Table 96. Breakdown of Oncology CRO Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 97. Market Position of Players in Oncology CRO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 98. Head Office of Key Oncology CRO Services Players
Table 99. Oncology CRO Services Market: Company Product Type Footprint
Table 100. Oncology CRO Services Market: Company Product Application Footprint
Table 101. Oncology CRO Services New Market Entrants and Barriers to Market Entry
Table 102. Oncology CRO Services Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Oncology CRO Services Consumption Value (USD Million) by Type (2020-2025)
Table 104. Global Oncology CRO Services Consumption Value Share by Type (2020-2025)
Table 105. Global Oncology CRO Services Consumption Value Forecast by Type (2026-2031)
Table 106. Global Oncology CRO Services Consumption Value by Application (2020-2025)
Table 107. Global Oncology CRO Services Consumption Value Forecast by Application (2026-2031)
Table 108. North America Oncology CRO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 109. North America Oncology CRO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 110. North America Oncology CRO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 111. North America Oncology CRO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 112. North America Oncology CRO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Oncology CRO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Oncology CRO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 115. Europe Oncology CRO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 116. Europe Oncology CRO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 117. Europe Oncology CRO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 118. Europe Oncology CRO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 119. Europe Oncology CRO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 120. Asia-Pacific Oncology CRO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 121. Asia-Pacific Oncology CRO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 122. Asia-Pacific Oncology CRO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 123. Asia-Pacific Oncology CRO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 124. Asia-Pacific Oncology CRO Services Consumption Value by Region (2020-2025) & (USD Million)
Table 125. Asia-Pacific Oncology CRO Services Consumption Value by Region (2026-2031) & (USD Million)
Table 126. South America Oncology CRO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 127. South America Oncology CRO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 128. South America Oncology CRO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 129. South America Oncology CRO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 130. South America Oncology CRO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 131. South America Oncology CRO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 132. Middle East & Africa Oncology CRO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 133. Middle East & Africa Oncology CRO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 134. Middle East & Africa Oncology CRO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 135. Middle East & Africa Oncology CRO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 136. Middle East & Africa Oncology CRO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 137. Middle East & Africa Oncology CRO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Global Key Players of Oncology CRO Services Upstream (Raw Materials)
Table 139. Global Oncology CRO Services Typical Customers
LIST OF FIGURES
Figure 1. Oncology CRO Services Picture
Figure 2. Global Oncology CRO Services Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Oncology CRO Services Consumption Value Market Share by Type in 2024
Figure 4. Preclinical Oncology CRO Services
Figure 5. Clinical Trial Management
Figure 6. Others
Figure 7. Global Oncology CRO Services Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Oncology CRO Services Consumption Value Market Share by Application in 2024
Figure 9. Pharmaceutical Companies Picture
Figure 10. Academic and Research Institutions Picture
Figure 11. Others Picture
Figure 12. Global Oncology CRO Services Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Oncology CRO Services Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Oncology CRO Services Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Oncology CRO Services Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Oncology CRO Services Consumption Value Market Share by Region in 2024
Figure 17. North America Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Oncology CRO Services Revenue Share by Players in 2024
Figure 24. Oncology CRO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Oncology CRO Services by Player Revenue in 2024
Figure 26. Top 3 Oncology CRO Services Players Market Share in 2024
Figure 27. Top 6 Oncology CRO Services Players Market Share in 2024
Figure 28. Global Oncology CRO Services Consumption Value Share by Type (2020-2025)
Figure 29. Global Oncology CRO Services Market Share Forecast by Type (2026-2031)
Figure 30. Global Oncology CRO Services Consumption Value Share by Application (2020-2025)
Figure 31. Global Oncology CRO Services Market Share Forecast by Application (2026-2031)
Figure 32. North America Oncology CRO Services Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Oncology CRO Services Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Oncology CRO Services Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Oncology CRO Services Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Oncology CRO Services Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Oncology CRO Services Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 42. France Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Oncology CRO Services Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Oncology CRO Services Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Oncology CRO Services Consumption Value Market Share by Region (2020-2031)
Figure 49. China Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 52. India Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Oncology CRO Services Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Oncology CRO Services Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Oncology CRO Services Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Oncology CRO Services Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Oncology CRO Services Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Oncology CRO Services Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 66. Oncology CRO Services Market Drivers
Figure 67. Oncology CRO Services Market Restraints
Figure 68. Oncology CRO Services Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Oncology CRO Services Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Oncology CRO Services Picture
Figure 2. Global Oncology CRO Services Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Oncology CRO Services Consumption Value Market Share by Type in 2024
Figure 4. Preclinical Oncology CRO Services
Figure 5. Clinical Trial Management
Figure 6. Others
Figure 7. Global Oncology CRO Services Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Oncology CRO Services Consumption Value Market Share by Application in 2024
Figure 9. Pharmaceutical Companies Picture
Figure 10. Academic and Research Institutions Picture
Figure 11. Others Picture
Figure 12. Global Oncology CRO Services Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Oncology CRO Services Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Oncology CRO Services Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Oncology CRO Services Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Oncology CRO Services Consumption Value Market Share by Region in 2024
Figure 17. North America Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Oncology CRO Services Revenue Share by Players in 2024
Figure 24. Oncology CRO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Oncology CRO Services by Player Revenue in 2024
Figure 26. Top 3 Oncology CRO Services Players Market Share in 2024
Figure 27. Top 6 Oncology CRO Services Players Market Share in 2024
Figure 28. Global Oncology CRO Services Consumption Value Share by Type (2020-2025)
Figure 29. Global Oncology CRO Services Market Share Forecast by Type (2026-2031)
Figure 30. Global Oncology CRO Services Consumption Value Share by Application (2020-2025)
Figure 31. Global Oncology CRO Services Market Share Forecast by Application (2026-2031)
Figure 32. North America Oncology CRO Services Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Oncology CRO Services Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Oncology CRO Services Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Oncology CRO Services Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Oncology CRO Services Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Oncology CRO Services Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 42. France Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Oncology CRO Services Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Oncology CRO Services Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Oncology CRO Services Consumption Value Market Share by Region (2020-2031)
Figure 49. China Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 52. India Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Oncology CRO Services Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Oncology CRO Services Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Oncology CRO Services Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Oncology CRO Services Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Oncology CRO Services Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Oncology CRO Services Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Oncology CRO Services Consumption Value (2020-2031) & (USD Million)
Figure 66. Oncology CRO Services Market Drivers
Figure 67. Oncology CRO Services Market Restraints
Figure 68. Oncology CRO Services Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Oncology CRO Services Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
